Biden administration’s negotiated price cuts for 10 common prescription drugs likely to save Medicare billions, beginning in 2026

The Biden administration announced on Aug. 16, 2024, the reduced prices of the first 10 drugs it has negotiated with pharmaceutical companies over their Medicare prices. Provisions authorizing these negotiations…

CRISPR and other new technologies open doors for drug development, but which diseases get prioritized? It comes down to money and science

Prescription drugs and vaccines revolutionized health care, dramatically decreasing death from disease and improving quality of life across the globe. But how do researchers, universities and hospitals, and the pharmaceutical…

Blame capitalism? Why hundreds of decades-old yet vital drugs are nearly impossible to find

Past public ire over high drug prices has recently taken a back seat to a more insidious problem – no drugs at any price. Patients and their providers increasingly face…